SCHEMBL454946

SCHEMBL454946

BrSc1[c]cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL819437 0.78 MAPT (0.32)
SCHEMBL2423602 0.78
SCHEMBL440187 0.76
SCHEMBL980439 0.74
SCHEMBL9189179 0.74
SCHEMBL2186947 0.74
SCHEMBL1276119 0.74
SCHEMBL97062 0.74
SCHEMBL16585731 0.74
SCHEMBL7309385 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024149234-A1 PARP7 INHIBITORS AND USES THEREOF Angel Pharmaceutical Co., Ltd. (CN) 2024-07-18 WO claimed
WO-2023090822-A1 NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION 강원대학교 산학협력단 2023-05-25 WO claimed
EP-1846387-A2 BIS-(COUMARIN) COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY GlaxoSmithKline istrazivacki centar Zagreb d.o.o. (HR) 2007-10-24 EP claimed
WO-2006111858-A2 BIS-(COUMARIN) COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (US) 2006-10-26 WO claimed
EP-1109787-B1 ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP) ASTRAZENECA AB (SE) 2006-05-17 EP claimed
WO-2005002514-A2 COMPOUNDS HAVING INHIBITIBE ACTIVITY OF PHOSPHATIDYLINOSITOL 3-KINASE AND METHODS OF USE THEREOF ECHELON BIOSCIENCES INCORPORATED (US) 2005-01-13 WO claimed
US-6734184-B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) ASTRAZENECA AB (SE) 2004-05-11 US claimed
US-20030100548-A1 Arylpiperazines and their use as metallaproteinase inhibiting agents (mmp) ASTRAZENECA AB (SE) 2003-05-29 US claimed
EP-1274697-A1 ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP) AstraZeneca AB (SE) 2003-01-15 EP claimed
WO-2001062750-A1 ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP) ASTRAZENECA AB (SE) 2001-08-30 WO claimed
WO-2001027119-A2 SUBSTANCE LIBRARY CONTAINING BICYCLIC IMIDAZO-5-YL-AMINES AND/OR BICYCLIC IMIDAZO-3-YL-AMINES Grünenthal GmbH (DE) 2001-04-19 WO claimed
WO-2024149234-A1 PARP7 INHIBITORS AND USES THEREOF Angel Pharmaceutical Co., Ltd. (CN) 2024-07-18 WO disclosed
WO-2023090822-A1 NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION 강원대학교 산학협력단 2023-05-25 WO disclosed
CN-110199401-B Organic solar cell 株式会社LG化学 2023-05-12 CN disclosed
WO-2016046779-A1 ZINC POLYAZAMACROCYCLIC COMPLEXES ENI S.P.A. (IT) 2016-03-31 WO disclosed
EP-0268178-A1 Pyrrolo-benzimidazoles, medicaments containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1988-05-25 EP disclosed
EP-0263352-A1 Imidazo-benzoxazinones, their preparation and medicaments containing these compounds Dr. Karl Thomae GmbH (DE) 1988-04-13 EP disclosed
EP-0172031-A1 Novel sulfenylated acylhydrazones, compositions containing them, methods of making them and their use ROHM AND HAAS COMPANY (US) 1986-02-19 EP disclosed
US-4361563-A CARDIOTONIC, ANTITHROMBOTIC DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1982-11-30 US disclosed
EP-0008391-A1 Benzimidazoles, their preparation and pharmaceutical compositions containing them Dr. Karl Thomae GmbH (DE) 1980-03-05 EP disclosed